N@N

FORT LAUDERDALE, Fla.--([ BUSINESS WIRE ])--Imaging Diagnostic Systems, Inc., (OTCBB:IMDS), a pioneer in laser optical breast imaging announced today that it has sold the first system of five ordered to be installed in Mexico. The system is scheduled to be installed during the third week of December. The purchase order was made through its exclusive distributor Kepter Internacional for Estados Unidos Mexicanos.

Kepter Internacional is scheduled to hold a presentation featuring the CTLM system and announcing its arrival to Mexico in January in front of the COFEPRIS (Health Ministry) of Mexico. Kepter Internacional is the exclusive agent for Imaging Diagnostic Systems, authorized to promote, distribute and service the CT Laser Mammography (CTLM) System throughout Mexico.

About Imaging Diagnostic Systems, Inc.

Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and shows the process of angiogenesis, which usually accompanies tumor growth. CTLM system has received international certifications and licenses from the European CE mark, CMDCAS Canadian Health screening, China SFDA, India, UL, and ISO 13485.

For more information, visit our website: [ www.imds.com ]

As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future, anticipated, or projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Companyas filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.